BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 6241903)

  • 1. Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine.
    Strauer BE; Atef Mahmoud M; Bayer F; Bohn I; Motz U
    Eur Heart J; 1984 Dec; 5 Suppl F():53-60. PubMed ID: 6241903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Doppler imaging assessment of long axis left ventricular function in hypertensive patients with concentric left ventricular hypertrophy: differential diagnosis with hypertrophic cardiomyopathy.
    Cardim N; Longo S; Ferreira T; Pereira A; Gouveia A; Reis RP; Correia JM
    Rev Port Cardiol; 2002 Jun; 21(6):709-40. PubMed ID: 12194374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of myocardial and coronary vascular hypertrophy in hypertensive heart disease.
    Strauer BE
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S45-54. PubMed ID: 2468873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological quantification and differentiation of left ventricular hypertrophy in hypertrophic cardiomyopathy and hypertensive heart disease. A two dimensional echocardiographic study.
    Keller H; Wanger KC; Goepfrich M; Stegaru B; Buss J; Heene DL
    Eur Heart J; 1990 Jan; 11(1):65-74. PubMed ID: 2137778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.
    Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF
    Circulation; 1982 Mar; 65(3):499-507. PubMed ID: 7198942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of hypertension in apical hypertrophy].
    Fujiwara S; Umemoto M; Miyamoto Y; Ota A; Arita M; Yokote Y; Nakamura Y; Ueno Y; Nishio I; Masuyama Y
    J Cardiogr Suppl; 1985; (6):53-64. PubMed ID: 4067356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary hemodynamics in hypertensive heart disease. Basic concepts, clinical consequences, and experimental analysis of regression of hypertensive microangiopathy.
    Strauer BE
    Am J Med; 1988 Mar; 84(3A):45-54. PubMed ID: 2975465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stress pulsed Doppler echocardiography in the evaluation of diastolic left ventricular function].
    Asai M; Oki T; Ohkushi H; Ishimoto T; Tominaga T; Taoka M; Fukuda N; Niki T; Mori H
    J Cardiogr; 1985 Jun; 15(2):399-413. PubMed ID: 2936836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progression and regression of heart hypertrophy in arterial hypertension: pathophysiology and clinical aspects].
    Strauer BE
    Z Kardiol; 1985; 74 Suppl 7():171-8. PubMed ID: 2936017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of cardiac structure and function after regression of cardiac hypertrophy.
    Habib GB; Mann DL; Zoghbi WA
    Am Heart J; 1994 Aug; 128(2):333-43. PubMed ID: 8037101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
    Senn M; Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine in the long-term management of hypertensive heart disease.
    Motz W; Strauer BE
    Hypertension; 1983; 5(4 Pt 2):II39-44. PubMed ID: 6222970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular hypertrophy in cardiomyopathy.
    Oakley C
    Br Heart J; 1971; 33(Suppl):Suppl:179-86. PubMed ID: 4252244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different pathophysiology of cardiac hypertrophy in hypertension and hypertrophic cardiomyopathy.
    Takeda A; Takeda N
    J Mol Cell Cardiol; 1997 Nov; 29(11):2961-5. PubMed ID: 9405171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil but not nifedipine impairs left ventricular function during exercise in hypertensive patients.
    Ashmore RC; Corkadel LK; Green CL; Horwitz LD
    Am Heart J; 1990 Mar; 119(3 Pt 1):636-41. PubMed ID: 2309606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol.
    Trimarco B; De Luca N; Rosiello G; Ricciardelli B; Betocchi S; Filardi PP; Raponi M; Condorelli M
    Am J Cardiol; 1989 Oct; 64(12):745-51. PubMed ID: 2572165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nifedipine on normal and ischemic left ventricular function during atrial pacing stress.
    Weiss AT; Shefer A; Lewis BS; Witt H; Halon DA; Gotsman MS
    Cardiology; 1984; 71(4):190-8. PubMed ID: 6478465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nifedipine on left ventricular diastolic function in patients with asymptomatic or minimally symptomatic hypertrophic cardiomyopathy.
    Yamakado T; Okano H; Higashiyama S; Hamada M; Nakano T; Takezawa H
    Circulation; 1990 Feb; 81(2):593-601. PubMed ID: 2297865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.